Welcome to our dedicated page for QT Imaging Holdings news (Ticker: QTIH), a resource for investors and traders seeking the latest updates and insights on QT Imaging Holdings stock.
QT Imaging Holdings (QTIH) delivers innovative medical imaging solutions through advanced diagnostic technology. This news hub provides investors and healthcare professionals with essential updates on the company's developments in non-invasive imaging systems and strategic initiatives.
Access timely press releases covering quarterly earnings, new product approvals, research breakthroughs, and partnership announcements. Our curated collection ensures you stay informed about QTIH's progress in enhancing diagnostic accuracy and expanding clinical applications of its imaging platforms.
Key updates include regulatory milestones, technology licensing agreements, and peer-reviewed study results. Bookmark this page for direct access to original source materials and analysis-free reporting on QTIH's contributions to medical imaging advancements.
QT Imaging Holdings (OTCQB:QTIH) has successfully delivered and installed its QT Imaging Breast Acoustic CT™ Scanner at Innovative Radiology in Des Moines, Iowa, marking the first installation of this technology in the state. The scanner utilizes proprietary low-frequency ultrasound technology to create high-resolution, 3D breast images without using ionizing radiation or compression, making it particularly beneficial for patients with dense breast tissue.
Led by Dr. John Tentinger, Innovative Radiology becomes the first facility in Iowa to offer this advanced imaging solution alongside their existing suite of diagnostic technologies, including mammography, MRI, CT, ultrasound, and X-ray. The installation represents a significant step in expanding access to radiation-free breast imaging technology in the region.
QT Imaging Holdings (OTCQB:QTIH), a medical device company focused on body imaging systems, has secured a $200,000 PIPE investment from Mr. Leon Recanati, vice chairman of Israel Cancer Association. The investment terms include the purchase of 205,339 unregistered common stock shares at $0.974 per share, representing a 10% premium to the 5-day VWAP as of May 9, 2025. The deal also includes 205,339 warrants with an exercise price of $1.12 per share.
The transaction, expected to close by May 19, 2025, was placed directly by the company without banking fees. The proceeds will be used as working capital to support business growth.
QT Imaging Holdings (OTCQB:QTIH) has secured a $500,000 PIPE investment from company insiders. Board Chairman Dr. Avi Katz and CEO Dr. Raluca Dinu have agreed to purchase 784,929 unregistered common stock shares at $0.637 per share, representing a 10% premium to the volume weighted average trading price on April 9, 2025.
The deal includes 1,569,858 warrants with an exercise price of $0.72 per share. The financing, expected to close by April 24, 2025, was placed directly by QTI without banking fees. The proceeds will be used as working capital to support the company's business growth.
QT Imaging Holdings (OTCQB:QTIH) has secured a $500,000 PIPE investment from company insiders. The investment comes from Board Chairman Dr. Avi Katz and CEO Dr. Raluca Dinu, who agreed to purchase 784,929 unregistered common stock shares at $0.637 per share on April 9, 2025.
The deal includes 1,569,858 warrants with an exercise price of $0.72 per share. The share price represents a 10% premium to the company's volume weighted average trading price. The financing, expected to close by April 24, 2025, was placed directly by QTI without banking fees. The proceeds will be used as working capital to support the company's business growth.
QT Imaging Holdings (OTCQB:QTIH) has announced its participation in the 2025 SBI Breast Imaging Symposium, scheduled for April 24-27 in Colorado Springs, Colorado. The company will showcase its innovative QT Breast Acoustic CT™ imaging technology at Canon Medical Systems' booth 535.
The technology represents a significant advancement in breast imaging, offering radiation-free and highly accurate breast scans. It is specifically designed to improve early detection of breast abnormalities and enhance patient outcomes, with particular effectiveness for women with dense breast tissue.
Dr. Bilal Malik, Chief Science Officer, emphasized the company's commitment to engaging with healthcare professionals and demonstrating how their technology aims to transform breast imaging practices globally. The company maintains its focus on advancing women's healthcare through innovative technologies and strategic partnerships.
QT Imaging Holdings (OTCQB:QTIH) has announced the successful shipment of six QT Breast Acoustic CT™ Systems in Q1 2025, generating total revenue of $2.7 million. The company met its previously projected targets, marking a significant milestone in its commercial expansion.
The achievement underscores the success of QTIH's strategic partnership with NXC Imaging, Inc. and reinforces their position in the breast imaging market. The company aims to continue advancing its product offerings and expanding its presence in the medical imaging industry.
QT Imaging Holdings (OTCQB: QTIH) reported its Q4 and full-year 2024 financial results, highlighting significant growth with revenue of $4.9 million from twelve QT Breast Acoustic CT Scanner shipments, achieving a 54% gross margin. The company secured key financial arrangements, including a $2.56 million PIPE investment from board members and a $10.1 million Lynrock Lake Term Loan.
Q4 2024 showed commercial revenue of $0.8 million with a 47% gross margin, though net loss was $3.5 million. The company cleared all short-term debt liabilities and established strategic partnerships with NXC Imaging for US distribution and Canon Medical Systems for manufacturing.
Looking ahead, QT Imaging projects strong revenue growth, forecasting $18 million for 2025 (40 scanners) and $27 million for 2026 (60 scanners), supported by minimum order quantities in their amended distribution agreement with NXC Imaging.
QT Imaging Holdings (OTCQB:QTIH), a medical device company focused on innovative body imaging systems, has successfully completed its uplisting to the OTCQB Venture Market. The company's stock began trading on the OTCQB on Tuesday, March 11, following approval from OTC Markets Group Inc. This strategic move is expected to enhance the company's market value, visibility, and transparency.
QT Imaging Holdings (OTC:QTIH) has secured $10.1 million in financing from Lynrock Lake Master Fund LP through a secured note maturing in March 2027. The funding will support working capital needs for 2025-2026, particularly for manufacturing products to fulfill orders under their distribution agreement with NXC Imaging.
The company has utilized part of the funds to repay the Cable Car Note and settle Yorkville Note obligations by paying $3 million in cash and issuing a 5-year warrant for 15 million shares. After debt settlements, $5.5 million remains for working capital before transaction costs.
The financing aims to support the delivery of at least 100 scanners over the next two years to their strategic partner, expected to generate $45 million in revenue.
FAQ
What is the current stock price of QT Imaging Holdings (QTIH)?
What is the market cap of QT Imaging Holdings (QTIH)?
